Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/oxford-university-press/identification-of-two-classes-of-prolactin-releasing-factors-in-X5RssX2shb
References (25)
-
M. Laudon, Daniel Grossman, N. Ben-Jonathan (1990)
Prolactin-releasing factor: cellular origin in the intermediate lobe of the pituitary.Endocrinology, 126 6
-
G. Thomas, B. Thorne, L. Thomas, R. Allen, D. Hruby, R. Fuller, J. Thorner (1988)
Yeast KEX2 endopeptidase correctly cleaves a neuroendocrine prohormone in mammalian cells.Science, 241 4862
-
G. Thomas, J. Cummins, B. Canny, S. Rundle, N. Griffin, S. Katsahambas, I. Clarke (1989)
The posterior pituitary regulates prolactin, but not adrenocorticotropin or gonadotropin, secretion in the sheep.Endocrinology, 125 4
-
N. Ben-Jonathan, M. Laudon, P. Garris (1991)
Novel aspects of posterior pituitary function : regulation of prolactin secretionFrontiers in Neuroendocrinology, 12
-
D. Autelitano, M. Blum, M. Lopingco, R. Allen, J. Roberts (1990)
Corticotropin-releasing factor differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and mature mRNA in vivo.Neuroendocrinology, 51 2
-
J. Hyde, I. Murai, N. Ben-Jonathan (1987)
The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perifused anterior pituitary cells.Endocrinology, 121 4
-
M. Low, B. Liu, G. Hammer, M. Rubinstein, R. Allen (1993)
Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene.The Journal of biological chemistry, 268 33
-
J. Dymshitz, M. Laudon, N. Ben-Jonathan (1992)
Endothelin-induced biphasic response of lactotrophs cultured under different conditions.Neuroendocrinology, 55 6
-
R. Allen, J. Hatfield, J. Stack (1988)
Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. I. Adrenocorticotropin (ACTH) and alpha-melanotropins (alpha-MSHs).Developmental biology, 126 1
-
Michael Selmanoff, Christine Shu, Richard Hartman, Charles Barraclough, Sandra Petersen, Sandra Petersen (1991)
Tyrosine hydroxylase and POMC mRNA in the arcuate region are increased by castration and hyperprolactinemia.Brain research. Molecular brain research, 10 3
-
M. Cronin, N. Faure, J. Martial, R. Weiner (1980)
Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.Endocrinology, 106 3
-
J. Hatfield, R. Allen, J. Stack, O. Rønnekleiv (1988)
Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development: II. β-lipotropin (β-LPH)-related peptides☆Developmental Biology, 126
-
B. Seizinger, V. Höllt, A. Herz (1984)
Postnatal development of beta-endorphin-related peptides in rat anterior and intermediate pituitary lobes: evidence for contrasting development of proopiomelanocortin processing.Endocrinology, 115 1
-
T. Porter, L. Frawley (1992)
Neurointermediate lobe peptides recruit prolactin-secreting cells exclusively within the central region of the adenohypophysis.Endocrinology, 131 6
-
I. Murai, S. Reichlin, N. Ben-Jonathan (1989)
The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.Endocrinology, 124 2
-
I. Murai, N. Ben-Jonathan (1990)
Acute stimulation of prolactin release by estradiol: mediation by the posterior pituitary.Endocrinology, 126 6
-
E. Ellerkmann, G. Nagy, L. Frawley (1991)
Rapid augmentation of prolactin cell number and secretory capacity by an estrogen-induced factor released from the neurointermediate lobe.Endocrinology, 129 2
-
Rosemary Steinmetz, Arthur Gutierrez-Hartmann, R. Bigsby, N. Ben-Jonathan (1994)
Activation of the prolactin promoter in transfected GH3 cells by posterior pituitary cells.Endocrinology, 135 6
-
J. Dymshitz, N. Ben-Jonathan (1991)
Coculture of anterior and posterior pituitary cells: selective stimulation of lactotrophs.Endocrinology, 128 5
-
M. Beaulieu, M. Goldman, K. Miyazaki, E. Frey, R. Eskay, J. Kebabian, T. Cote (1984)
Bromocriptine-induced changes in the biochemistry, physiology, and histology of the intermediate lobe of the rat pituitary gland.Endocrinology, 114 5
-
B. Chronwall, W. Millington, W. Griffin, J. Unnerstall, T. O'Donohue (1987)
Histological evaluation of the dopaminergic regulation of proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary, involving in situ hybridization and [3H]thymidine uptake measurement.Endocrinology, 120 3
-
A. Corcia, R. Steinmetz, J. Liu, N. Ben-Jonathan (1993)
Coculturing posterior pituitary and GH3 cells: dramatic stimulation of prolactin gene expression.Endocrinology, 132 1
-
J. Hyde, N. Ben-Jonathan (1988)
Characterization of prolactin-releasing factor in the rat posterior pituitary.Endocrinology, 122 6
-
W. Samson, K. Skala, B. Alexander, F. Huang (1990)
Pituitary site of action of endothelin: selective inhibition of prolactin release in vitro.Biochemical and biophysical research communications, 169 2
-
R. Averill, D. Grattan, S. Norris (1991)
Posterior pituitary lobectomy chronically attenuates the nocturnal surge of prolactin in early pregnancy.Endocrinology, 128 2
- Publisher
- Oxford University Press
- Copyright
- Copyright © 1995 by The Endocrine Society
- ISSN
- 0013-7227
- eISSN
- 1945-7170
- DOI
- 10.1210/endo.136.7.7789336
- Publisher site
- See Article on Publisher Site
Abstract
Abstract Targeted tumorigenesis, using the POMC gene promoter ligated to the simian virus 40 large T antigen, generated transgenic mice with massive tumors of the intermediate lobe (IL) of the pituitary. Inoculation of nude mice with the IL tumor cells resulted in very large secondary tumors. As the IL from several species produces a potent PRL-releasing factor (PRF), it was of interest to determine whether IL tumors from these mice also contain PRF. The objectives were to 1) measure serum PRL levels in mice with IL tumors, 2) determine whether these tumors contain PRF and examine its chromatographic properties, and 3) analyze whether this PRF is related to POMC, its derivatives, or other PRL secretagogues. Serum PRL levels were 5- to 6-fold higher in transgenic than in control mice. Primary and secondary IL tumors were acid extracted and successively fractionated using Sephadex G-100 gel filtration and reverse phase and gel permeation HPLC. PRF activity was determined using short term incubation of tissue extracts or column fractions with GH3 cells. Crude tumor extracts exhibited a strong and dose-dependent PRF activity. Upon chromatography, the PRF activity from either primary or secondary tumors resolved into two classes of compounds: a big PRF with an estimated mol wt of 70-80 kilodaltons and two small, very hydrophobic peptides. The elution profiles of the three PRFs differed from those of beta-endorphin, alpha MSH, beta MSH, ACTH, TRH, oxytocin, angiotensin II, vasoactive intestinal polypeptide, or corticotropin-like intermediate peptide. In summary, we have identified an animal model with IL tumors that has hyperprolactinemia and overproduces PRF. Two classes of PRFs, big and small, were resolved which differ from POMC derivatives and known regulators of PRL release. These data suggest that PRF is produced by melanotrophs, but is not a product of the POMC gene. The IL tumors should provide an excellent source for the purification and structural elucidation of PRFs. This content is only available as a PDF. Copyright © 1995 by The Endocrine Society
Journal
Endocrinology – Oxford University Press
Published: Jul 1, 1995